Exhibit 99.1
Report of Voting Results
Aptose Biosciences Inc.
In accordance with Section 11.3 of National Instrument 51-102, the following describes the matters voted upon and the outcome of the votes at the annual and special meeting of shareholders of Aptose Biosciences Inc. (the “Corporation”) held on June 21, 2016 in Toronto, Ontario.
Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
Dr. Denis Burger | 6,971,868 | 99.79 | 14,813 | 0.21 |
Dr. Erich Platzer | 6,971,779 | 99.79 | 14,902 | 0.21 |
Dr. William G. Rice | 6,947,058 | 99.43 | 39,623 | 0.57 |
Dr. Bradley Thompson | 6,966,495 | 99.71 | 20,186 | 0.29 |
Dr. Mark D. Vincent | 6,971,878 | 99.79 | 14,803 | 0.21 |
Warren Whitehead | 6,971,468 | 99.78 | 15,213 | 0.22 |
In total, approximately 57.40% of the issued and outstanding shares were represented in person or by proxy at the meeting.
Yours very truly,
/s/ Gregory Chow
Gregory Chow
Senior Vice President and Chief Financial Officer